Status | Study |
Recruiting |
Study Name: Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy Condition: Metabolism, Inborn Errors Lipid Metabolism, Inborn Errors Date: 2015-12-09 Interventions: Other: Sugar 10 minutes before exercising, the subjects are given a bolus of glucose solution 0.2 g/kg i |
Enrolling by invitation |
Study Name: Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies. Condition: Carnitine Palmitoyltransferase (CPT I or CPT II) Deficiency Ver Date: 2014-08-06 Interventions: Drug: UX007 Subjects will begin or continue treatment with daily open-label UX007 while maintaining thei |
Completed |
Study Name: An Open-label Phase 2 Study of UX007 (Triheptanoin) in Subjects With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Condition: Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) Carnitine Palmitoyltransferase ( Date: 2013-06-18 Interventions: Drug: UX007 Other Names: Triheptanoin C7 oil |
Completed |
Study Name: High Protein Diet in Patients With Long-chain Fatty Acid Oxidation Disorders Condition: Very Long-chain Acyl-CoA Dehydrogenase Deficiency Trifunctional Protein Deficiency Date: 2011-12-14 Interventions: Behavioral: Diet counseling Subjects counseled how to follow either the high carbohydrate diet or the hi |
Completed |
Study Name: Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects Condition: Carnitine Palmitoyltransferase II Deficiency Very Long Chain Ac Date: 2009-09-23 Interventions: Drug: Bezafibrate 3 x 200 mg/ |
Recruiting |
Study Name: Bezafibrate Trial in CPT2 Deficiency Condition: Carnitine Palmitoyl Transferase 2 Deficiency Date: 2006-06-09 Interventions: Drug: bezafibrate (drug) |